Ra Capital Healthcare Fund Lp
10% Owner at Adicet Bio, Inc. (ACET); Director at Artiva Biotherapeutics, Inc. (ARTV); Director at Climb Bio, Inc. (CLYM); 10% Owner at Hemab Therapeutics Holdings, Inc. (COAG); 10% Owner at Fulcrum Therapeutics, Inc. (FULC); Director at SpyGlass Pharma, Inc. (SGP)
Purchase track record
Strong record. Based on 4 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 31SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 20,82417,304,626 held (+0%) | $9.99 | $208K | -30.5% |
| Jul 31SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 24,94417,329,570 held (+0%) | $9.93 | $248K | -30.1% |
| Jul 20SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 152,47216,970,045 held (+1%) | $8.93 | $1.4M | -22.3% |
| Jul 20SEC | ARTVArtiva Biotherapeutics, Inc. | Buy | 7,88216,977,927 held (+0%) | $8.95 | $71K | -22.5% |
| May 11SEC | COAGHemab Therapeutics Holdings, Inc. | Buy | 7,9216,322,446 held (+0%) | $24.34 | $193K | +29.9% |
| May 11SEC | COAGHemab Therapeutics Holdings, Inc. | Buy | 1,9856,324,431 held (+0%) | $24.95 | $50K | +26.7% |
| May 11SEC | COAGHemab Therapeutics Holdings, Inc. | Buy | 1,4836,325,914 held (+0%) | $24.98 | $37K | +26.6% |
| May 11SEC | COAGHemab Therapeutics Holdings, Inc. | Buy | 14,1496,340,063 held (+0%) | $24.47 | $346K | +29.2% |
| May 11SEC | COAGHemab Therapeutics Holdings, Inc. | Buy | 25,7206,365,783 held (+0%) | $25.00 | $643K | +26.5% |
| Apr 13SEC | ACETAdicet Bio, Inc. | Buy | 74,5771,033,605 held (+8%) | $7.04 | $525K | -20.3% |
| Apr 13SEC | ACETAdicet Bio, Inc. | Buy | 74,2681,107,873 held (+7%) | $7.21 | $535K | -22.2% |
| Apr 13SEC | ACETAdicet Bio, Inc. | Buy | 74,7511,182,624 held (+7%) | $7.27 | $543K | -22.8% |
| Feb 11SEC | SGPSpyGlass Pharma, Inc. | Buy | 3,441,9665,966,439 held (+136%) | $16.00 | $55.1M | +55.8% |
| Feb 11SEC | SGPSpyGlass Pharma, Inc. | Buy | 248,0342,054,678 held (+14%) | $16.00 | $4.0M | +55.8% |
| Jan 7SEC | CLYMClimb Bio, Inc. | Buy | 7,1113,403,429 held (+0%) | $3.50 | $25K | +214.3% |
| Dec 10SEC | FULCFulcrum Therapeutics, Inc. | Sell | 1,377,0208,852,079 held (−13%) | $13.33 | $18.4M | -71.7% |
| Dec 10SEC | FULCFulcrum Therapeutics, Inc. | Sell | 2,706,3976,145,682 held (−31%) | $14.28 | $38.6M | -73.6% |
| Dec 10SEC | FULCFulcrum Therapeutics, Inc. | Sell | 91,7226,053,960 held (−1%) | $14.98 | $1.4M | -74.8% |
- Buy
Director Ra Capital Healthcare Fund Lp bought $1.4M of ARTV at $8.93 — first open-market purchase in our records.
- Buy
10% Owner Ra Capital Healthcare Fund Lp bought $193K of COAG at $24.34 — first open-market purchase in our records.
- Buy
10% Owner Ra Capital Healthcare Fund Lp bought $346K of COAG at $24.47 — largest purchase by this insider in our records.
- Buy
10% Owner Ra Capital Healthcare Fund Lp bought $643K of COAG at $25.00 — largest purchase by this insider in our records.
- Buy
10% Owner Ra Capital Healthcare Fund Lp bought $525K of ACET at $7.04 — first open-market purchase in our records.
- Buy
Director Ra Capital Healthcare Fund Lp bought $55.1M of SGP at $16.00 — first open-market purchase in our records; raises the stake by 136%.